NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that clinical data from a ...
NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug ...
Hunterdon Medical Center and The Institute for Advanced Reconstruction proudly announce being the first healthcare providers on the East Coast to use the Lumicell® Direct Visualization System for ...
Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...
Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, announced today that it will be featured on Health Uncensored with Dr. Drew, a national ...
As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...
Lumicell Inc. sees a brighter future now that it has secured U.S. FDA approval for both its new drug application for Lumisight (pegulicianine) optical imaging agent and premarket approval for the ...
NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the U.S. commercial ...
Massachusetts-based Lumicell has received a Phase I Small Business Innovation Research contract from the National Cancer Institute (NCI), for development of an endoscopic imaging system for diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results